参麦注射液联合AG化疗方案对晚期不可切除胰腺癌患者肿瘤标志物及免疫功能的影响
Effects of Shenmai Injection Combined with AG Chemotherapy Regimen on Tumor Markers and Immune Function in Patients with Advanced Unresectable Pancreatic Cancer/TIAN Ning, ZHANG Shanyan, ZHOU Yuan, WANG Juan. //Medical Innovation of China, 2025, 22(12): 017-020[Abstract]Objective: To explorethe effects of Shenmai Injection combined with AG chemotherapy regimen on tumor markers and immune function in patients with advanced unresectable pancreatic cancer.Method: The clinical data of 80 patients with advanced unresectable pancreatic cancer admited to Tai'an Tumour Prevention and Treatment HospitalfromJanuary 2021 to June 2023 wereretrospectively analyzed,and they were divided into obsrvation group and control group according to diferent treatment regimens, with 40 cases in each group.The control group was treated with AG chemotherapy regimen,and the observation group was treated with Shenmai Injection on the basis of control group.Tumor markers,immunefunction and clinical efficacy were compared between the two groups. Result: After treatment, the levels of carcinoembryonic antigen (CEA)and carbohydrate antigen 19-9 (CA19-9)in both groups were decreased ......
您现在查看是摘要页,全文长 12919 字符。